#news #biotech Novavax COVID-19 vaccine 90% efficacious in phase 3 but protection plummets against one variant

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novavax COVID-19 vaccine 90% efficacious in phase 3 but protection plummets against one variant .Novavax COVID-19 vaccine 90% efficacious in phase 3 but protection plummets against one variant
ntaylor
Fri, 01/29/2021 – 04:53

from FierceBiotech: Biotech https://ift.tt/3agMVML